Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))

C. Craddock; J. Anson; P. Chu; A. Dodgson; N. Duncan; C. Gomez; J. Mehta; S. Sadullah; C. Subudhi; J. L. Yin

doi:10.1517/14740338.2011.561692

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))

C. Craddock^*
, J. Anson
, P. Chu
, A. Dodgson
, N. Duncan
, C. Gomez
, J. Mehta
, S. Sadullah
, C. Subudhi
, J. L. Yin

^*Corresponding author for this work

Manchester Lab

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	335
Number of pages	1
Journal	Expert Opinion on Drug Safety
Volume	10
Issue number	2
DOIs	https://doi.org/10.1517/14740338.2011.561692
Publication status	Published - Mar 2011

Access to Document

10.1517/14740338.2011.561692

Cite this

Craddock, C., Anson, J., Chu, P., Dodgson, A., Duncan, N., Gomez, C., Mehta, J., Sadullah, S., Subudhi, C., & Yin, J. L. (2011). Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147)). Expert Opinion on Drug Safety, 10(2), 335. https://doi.org/10.1517/14740338.2011.561692

@article{e701d4d105c84659ae707a7449f69499,

title = "Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))",

author = "C. Craddock and J. Anson and P. Chu and A. Dodgson and N. Duncan and C. Gomez and J. Mehta and S. Sadullah and C. Subudhi and Yin, \{J. L.\}",

year = "2011",

month = mar,

doi = "10.1517/14740338.2011.561692",

language = "English",

volume = "10",

pages = "335",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

Craddock, C, Anson, J, Chu, P, Dodgson, A, Duncan, N, Gomez, C, Mehta, J, Sadullah, S, Subudhi, C & Yin, JL 2011, 'Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))', Expert Opinion on Drug Safety, vol. 10, no. 2, pp. 335. https://doi.org/10.1517/14740338.2011.561692

TY - JOUR

T1 - Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))

AU - Craddock, C.

AU - Anson, J.

AU - Chu, P.

AU - Dodgson, A.

AU - Duncan, N.

AU - Gomez, C.

AU - Mehta, J.

AU - Sadullah, S.

AU - Subudhi, C.

AU - Yin, J. L.

PY - 2011/3

Y1 - 2011/3

UR - https://www.scopus.com/pages/publications/79952338874

U2 - 10.1517/14740338.2011.561692

DO - 10.1517/14740338.2011.561692

M3 - Comment/debate

AN - SCOPUS:79952338874

SN - 1474-0338

VL - 10

SP - 335

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

IS - 2

ER -

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex (Expert Opinion on Drug Safety (2010) 9, 1, (139-147))

Access to Document

Other files and links

Cite this